Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Daja

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Endocrinology|April 1, 1993
The detection and isolation of protease activity associated with purified preparations of human chorionic gonadotropinM M Daja, J Hiyama, G K Scott, et al.
European Review for Medical and Pharmacological Sciences|December 10, 2021
CNV analysis in a diagnostic setting using target panelE Sorrentino, M Daja, F Cristofoli, et al.
Journal of Diabetes|January 6, 2016
Once-daily liraglutide (1.2 mg) compared with twice-daily exenatide (10 μg) in the treatment of type 2 diabetes patients: An indirect treatment comparison meta-analysisStephen M Twigg, Mirella M Daja, Beth A O'leary, et al.
Prostate Cancer and Prostatic Diseases|March 29, 2003
Characterization of expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in prostate cancer cell linesM M Daja, X Niu, Z Zhao, et al.
Electrophoresis|April 20, 2004
Application of in-gel protease assay in a biological sample: characterization and identification of urokinase-type plasminogen activator (uPA) in secreted proteins from a prostate cancer cell line PC-3Zhenjun Zhao, Mark J Raftery, Xiao Mei Niu, et al.
Molecular Urology|January 13, 2001
Beta-human chorionic gonadotropin in semen: a marker for early detection of prostate cancer?M M Daja, M Aghmesheh, K T Ow, et al.
Human Gene Therapy|August 7, 1998
In vivo gene therapy for prostate cancer: preclinical evaluation of two different enzyme-directed prodrug therapy systems delivered by identical adenovirus vectorsR Martiniello-Wilks, J Garcia-Aragon, M M Daja, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Endocrinology|April 1, 1993
The detection and isolation of protease activity associated with purified preparations of human chorionic gonadotropinM M Daja, J Hiyama, G K Scott, et al.
European Review for Medical and Pharmacological Sciences|December 10, 2021
CNV analysis in a diagnostic setting using target panelE Sorrentino, M Daja, F Cristofoli, et al.
Journal of Diabetes|January 6, 2016
Once-daily liraglutide (1.2 mg) compared with twice-daily exenatide (10 μg) in the treatment of type 2 diabetes patients: An indirect treatment comparison meta-analysisStephen M Twigg, Mirella M Daja, Beth A O'leary, et al.
Prostate Cancer and Prostatic Diseases|March 29, 2003
Characterization of expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in prostate cancer cell linesM M Daja, X Niu, Z Zhao, et al.
Electrophoresis|April 20, 2004
Application of in-gel protease assay in a biological sample: characterization and identification of urokinase-type plasminogen activator (uPA) in secreted proteins from a prostate cancer cell line PC-3Zhenjun Zhao, Mark J Raftery, Xiao Mei Niu, et al.
Molecular Urology|January 13, 2001
Beta-human chorionic gonadotropin in semen: a marker for early detection of prostate cancer?M M Daja, M Aghmesheh, K T Ow, et al.
Human Gene Therapy|August 7, 1998
In vivo gene therapy for prostate cancer: preclinical evaluation of two different enzyme-directed prodrug therapy systems delivered by identical adenovirus vectorsR Martiniello-Wilks, J Garcia-Aragon, M M Daja, et al.
Pageof 1